N-0861 selectively antagonizes adenosine A1 receptors in vivo
- 27 May 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 216 (1) , 9-16
- https://doi.org/10.1016/0014-2999(92)90202-f
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Novel therapeutics acting via purine receptorsBiochemical Pharmacology, 1991
- Adenosine: A Physiological Brake on Renin ReleaseAnnual Review of Pharmacology and Toxicology, 1991
- Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise.Circulation, 1990
- Acute Renal Failure in Man: New Aspects Concerning PathogenesisAmerican Journal of Nephrology, 1990
- The cardiac effects of adenosineProgress in Cardiovascular Diseases, 1989
- The vasodilator role of adenosinePharmacology & Therapeutics, 1989
- Cardiovascular effects of adenosine in man; possible clinical implicationsProgress in Neurobiology, 1986
- Comparison of the potency of 8−phenyltheophylline as an antagonist at A1 and A2 adenosine receptors in atria and aorta from the guinea-pigJournal of Pharmacy and Pharmacology, 1985
- Presynaptic inhibition of vascular sympathetic neurotransmission by adenosineEuropean Journal of Pharmacology, 1981
- FEMORAL VASCULAR RESPONSES TO PURINE ANDPYRIMIDINE DERIVATIVES: RELEASE OF5-HYDROXYTRYPTAMINE BY PURINE DERIVATIVESIN ISOLATED, CROSS-CIRCULATED RAT HINDLIMB*The Japanese Journal of Pharmacology, 1979